Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
2020-06-04
SCID: 54.1/422nynk7
Discuss with AI
Cardiovascular DiseaseCovid-19Drug TherapyMortalityRetraction
Figures from the paper
Abstract (AI)
To the Editor: Because all the authors were not granted access to the raw data and the raw data could not be made available to a third-party auditor, we are unable to validate the primary data sour...
Key Findings
1
Inability to validate the primary data sources undermines the reliability of the study's findings regarding cardiovascular disease, drug therapy, and COVID-19 mortality
2
The authors explicitly acknowledge that lack of raw-data access and auditability is a critical limitation that prompted retraction
3
The paper was retracted because not all authors had access to the raw data and those data could not be provided to a third-party auditor, preventing validation of the primary data sources
Research Object
Study linking cardiovascular disease and drug therapy to mortality outcomes in COVID-19 patients (retracted NEJM article)
Research Subject
Validity and reliability of the primary data underlying associations between cardiovascular disease, specific drug therapies, and mortality in COVID-19 (data access and auditability issues leading to retraction)
Publication Details
Publication Date
2020-06-04
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest